Cognitive assessment scale for stroke patients (CASP): A multicentric validation study

Benaïm, Charles; Wauquiez, Grégoire; Pérennou, Dominic; Piscicelli, Céline; Lucas-Pineau, B.; Bonnin-Koang, Huei-Yune; Vuadens, Philippe; Binquet, Christine; Bourredjem, Abderrahmane; Devilliers, H.

doi:10.1016/j.rehab.2021.101594

Cited by 10 publications

(3 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The CASP consists of nine items evaluating six cognitive functions: language, praxis, short-term memory, temporal orientation, spatial/visuoconstruction neglect and executive functions. It has demonstrated good internal consistency (Cronbach’s alpha: 0.78 (95% CI 0.69 to 0.83) excellent inter-rater (ICCs: 0.78, 95% CI 0.73 to 0.83)) and intrarater reliability (ICCs: 0.85, 95% CI 0.79 to 0.89) 35…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Sequential multiple assignment randomised trial to develop an adaptive mobile health intervention to increase physical activity in people poststroke in the community setting in Ireland: TAPAS trial protocol

Carr,

Whiston,

O'Reilly

et al. 2024

BMJ Open

View full text Add to dashboard Cite

IntroductionStroke is the second-leading cause of death and disability globally. Participation in physical activity (PA) is a cornerstone of secondary prevention in stroke care. Given the heterogeneous nature of stroke, PA interventions that are adaptive to individual performance are recommended. Mobile health (mHealth) has been identified as a potential approach to supporting PA poststroke. To this end, we aim to use a Sequential Multiple Assignment Randomised Trial (SMART) design to develop an adaptive, user-informed mHealth intervention to improve PA poststroke.Methods and analysisThe components included in the 12-week intervention are based on empirical evidence and behavioural change theory and will include treatments to increase participation in Structured Exercise and Lifestyle or a combination of both. 117 participants will be randomly assigned to one of the two treatment components. At 6 weeks postinitial randomisation, participants will be classified as responders or non-responders based on participants’ change in step count. Non-responders to the initial treatment will be randomly assigned to a different treatment allocation. The primary outcome will be PA (steps/day), feasibility and secondary clinical and cost outcomes will also be included. A SMART design will be used to evaluate the optimum adaptive PA intervention among community-dwelling, ambulatory people poststroke.Ethics and disseminationEthical approval has been granted by the Health Service Executive Mid-Western Ethics Committee (REC Ref: 026/2022). The findings will be submitted for publication and presented at relevant national and international academic conferencesTrials registration numberNCT05606770.

show abstract

Section: Discussionmentioning

confidence: 99%

“…It has demonstrated good internal consistency (Cronbach's alpha: 0.78 (95% CI 0.69 to 0.83) excellent inter-rater (ICCs: 0.78, 95% CI 0.73 to 0.83)) and intrarater reliability (ICCs: 0.85, 95% CI 0.79 to 0.89). 35 ► Stroke recurrence: yes/no and date. ► Adverse effects: death: yes/no and date.…”

Section: Primary Outcomementioning

confidence: 99%

Sequential multiple assignment randomised trial to develop an adaptive mobile health intervention to increase physical activity in people poststroke in the community setting in Ireland: TAPAS trial protocol

Carr,

Whiston,

O'Reilly

et al. 2024

BMJ Open

View full text Add to dashboard Cite

show abstract

“…-Bilateral impairment; -Presence of aphasia; -Presence of cognitive impairment, as assessed using the cognitive assessment scale for patients with stroke (22), to avoid interference of aphasia or hemispatial neglect that may occur with the commonly used Mini-Mental State Examination (23) and Montreal Cognitive Assessment (24); -Stroke diagnosis without the occurrence of hemiparesis of the upper limb; -Previous rehabilitation.…”

Section: Eligibility Criteriamentioning

confidence: 99%

ROBOCOP (ROBOtic Care of Poststroke Pain): Study Protocol for a Randomized Trial to Assess Robot-Assisted Functional and Motor Recovery and Impact on Poststroke Pain Development

et al. 2022

View full text Add to dashboard Cite

BackgroundStroke is one of the most frequent causes of death and disability worldwide. It is accompanied by the impaired motor function of the upper extremities in over 69% of patients up to hemiplegia in the following 5 years in 56% of cases. This condition often is characterized by chronic poststroke pain, difficult to manage, further worsening quality of life. Poststroke pain occurs within 3–6 months. Robot-assisted neurorehabilitation using the Automatic Recovery Arm Motility Integrated System (ARAMIS) has proven efficacy in motor function recovery exploiting the movements and the strength of the unaffected arm. The rationale of the ROBOCOP (ROBOtic Care of Poststroke pain) randomized trial is the assessment of the impact of robot-assisted functional and motor recovery on the prevention of poststroke pain.MethodsA total of 118 patients with hemiplegic arms due to stroke will be enrolled and randomly allocated with a 1:1 ratio to ARAMIS or conventional neurorehabilitation group. After a baseline screening at hospital discharge, ARAMIS or conventional rehabilitation will be performed for 8 weeks. The primary endpoint is the prevention of the development of poststroke pain and the secondary endpoints are prevention of spasticity and efficacy in clinical motor rehabilitation. The primary outcome measures consist in the visual analog scale and the doleur neuropatique 4 and the secondary outcome measures include: the Modified Ashworth Scale, the Resistance to Passive movement Scale; the Upper Extremity Subscale of the Fugl–Meyer Motor Assessment; the Action Research Arm Test; the Barthel Index for activities of daily living; and the magnetic resonance imaging (MRI) recovery-related parameters. After baseline, both primary and secondary outcome measures will be performed in the following time points: 1 month after stroke (t1, half of the rehabilitation); 2 months after stroke (t2, after rehabilitation); and 3 months (t3) and 6 months (t4) after stroke, critical for poststroke pain development.DiscussionThis is the first clinical trial investigating the efficacy of robot-assisted neurorehabilitation using ARAMIS on poststroke pain prevention. This study could remarkably improve the quality of life of stroke survivors.

show abstract

Traducción y adaptación cultural de: THE COGNITIVE ASSESSMENT SCALE FOR STROKE PATIENTS. Protocolo de estudio

Andura

2023

Revista de Logopedia, Foniatría y Audiología

View full text Add to dashboard Cite

Cognitive assessment scale for stroke patients (CASP): A multicentric validation study

Cited by 10 publications

References 24 publications

Sequential multiple assignment randomised trial to develop an adaptive mobile health intervention to increase physical activity in people poststroke in the community setting in Ireland: TAPAS trial protocol

Sequential multiple assignment randomised trial to develop an adaptive mobile health intervention to increase physical activity in people poststroke in the community setting in Ireland: TAPAS trial protocol

ROBOCOP (ROBOtic Care of Poststroke Pain): Study Protocol for a Randomized Trial to Assess Robot-Assisted Functional and Motor Recovery and Impact on Poststroke Pain Development

Traducción y adaptación cultural de: THE COGNITIVE ASSESSMENT SCALE FOR STROKE PATIENTS. Protocolo de estudio

Contact Info

Product

Resources

About